Assessment of Background Parenchymal Enhancement at Dynamic Contrast-enhanced MRI in Predicting Breast Cancer

Dooman Arefan1, Margarita L Zuley1, Wendie A Berg1

  • 1From the Department of Radiology, University of Pittsburgh School of Medicine, 3240 Craft Pl, Room 322, Pittsburgh, PA 15213 (D.A., M.L.Z., W.A.B., L.Y., J.H.S., S.W.); Department of Radiology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA, 15213 (M.L.Z., W.A.B., J.H.S.); Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China (L.Y.); and Department of Biomedical Informatics (S.W.), Department of Bioengineering (S.W.), and Intelligent Systems Program (S.W.), University of Pittsburgh, Pittsburgh, Pa.

Radiology
|January 23, 2024
PubMed
Summary

Quantitative background parenchymal enhancement (BPE) on MRI can predict breast cancer recurrence risk, similar to the Oncotype DX score. This imaging measure helps identify high-risk patients, aiding in personalized treatment strategies.